Japanese encephalitis virus
CRS has successfully performed a phase III clinical trial on a new encephalitis vaccine
The Japanese encephalitis (JE) is caused by the Japanese encephalitis virus (JEV). JEV is a flavivirus, a genus in the family Flaviviridae, which is related to dengue, yellow fever and West Nile viruses. The flavivirus infects both, animals and humans and is spread through infected arthropods, in particular through mosquito or tick bites.
JEV is the most frequent cause of a viral encephalitis in Asia, with most cases seen in children in the age under 15 years, although the infection rate in people aged over 50 years is increasing.
JE is one of the most significant forms of epidemic viral encephalitis and can be prevented with a vaccine. CRS has already performed a Phase III clinic al trial to investigate the safety and tolerability of a new vaccine against JE.
CRS would be proud to become also your partner and jointly help to launch new and successful therapies on the market.